Selected Citations for Biomatik’s Custom Antibody Services
Recombinant antibodies offer researchers a consistent, scalable, and fully sequence-defined alternative to traditional antibody production. Biomatik provides recombinant antibody production services following de novo antibody sequencing or using customer-supplied sequences , enabling dependable antibody supply for long-term research or preclinical development . Our recombinant antibodies are manufactured with the same specificity and affinity as the original template antibody, while eliminating batch-to-batch variability.
Biomatik has been working with scientists worldwide for over 20 years. We are proud to offer trusted, high-quality recombinant antibody production services designed for reproducibility, consistency, and dependable performance in research applications.
Our recombinant antibody service includes:
• Gene synthesis
• Expression identification and antibody screening
• Expression and purification of the recombinant antibody
• Delivery of recombinant antibody (≥1.0 mg, 90 %) and 4 µg plasmid containing the gene insert
• QC and ELISA binding verification
• Optional large-scale production
Full details of our services including turnaround times, pricing, and deliverables can be found by downloading our recombinant antibody service packages. These packages typically involve antibody sequencing of your antibody of interest, however we can also produce your antibody from a supplied sequence.
Recombinant antibody technology allows researchers to produce monoclonal antibodies using defined gene sequences, rather than relying on traditional hybridoma or polyclonal methods. By cloning the antibody’s heavy and light chain genes into an expression system, recombinant antibodies offer unmatched consistency, batch-to-batch reproducibility, and scalability. Once produced, recombinant antibodies can be scaled up reliably across batches, modified for specific applications, or expressed in different host systems.
Recombinant antibodies offer:
• Guaranteed sequence accuracy
• Consistent performance and supply
• Scalability for larger studies
• Elimination of hybridoma stability or contamination issues
• Flexibility for antibody engineering or modification
Getting started is simple:
1. Provide your target antibody or sequence
2. Receive a customized quote and project timeline
3. Approve and begin production
